Ryan Ungaro
Icahn School of Medicine at Mount Sinai
H-index: 43
North America-United States
Top articles of Ryan Ungaro
P509 Upadacitinib improves symptomatic responses in patients with moderately to severely active Crohn’s disease
Journal of Crohn's and Colitis
2024/1/1
Real-World Effectiveness of Ustekinumab in Ulcerative Colitis in a United States Multicenter Cohort Consortium
Inflammatory Bowel Diseases
2024/3/26
P420 Natural history of intra-abdominal inflammatory masses (phlegmons) in Crohn’s disease
Journal of Crohn's and Colitis
2024/1/1
DOP33 Distinct perturbances in metabolic pathways associate with disease progression in patients with Inflammatory Bowel Disease
Journal of Crohn's and Colitis
2024/1/1
Shorter Crohn’s Disease Duration Is Associated With Better Clinical and Endoscopic Outcomes With Risankizumab in Phase 3 Studies
Gastro Hep Advances
2024/3/7
Problem with Hookups: Perianal Fistula After Ileal Pouch-Anal Anastomosis
Digestive Diseases and Sciences
2024/3/6
Ryan Ungaro
H-Index: 23
P439 Mild Crohn’s disease is characterized by a unique serum metabolomic signature
Journal of Crohn's and Colitis
2024/1/1
DOP68 Natural history of isolated Crohn's Disease perianal fistula
Journal of Crohn's and Colitis
2024/1/1
Clinical Long-Term Outcomes of Patient-Reported Outcomes in the Prospective Real-World Tofacitinib Response in Ulcerative Colitis Registry
Clinical and translational gastroenterology
2024/3/1
Defining Endoscopic Remission in Crohn’s Disease: MM-SES-CD and SES-CD Thresholds Associated with Low Risk of Disease Progression
Clinical Gastroenterology and Hepatology
2024/2/28
DOP05 Bowel damage and its correlation with the disability index in patients with recently diagnosed Crohn´ s Disease
Journal of Crohn's and Colitis
2024/1/1
Long-Term Effectiveness and Durability of COVID-19 Vaccination among Patients with Inflammatory Bowel Disease
Clinical Gastroenterology and Hepatology
2024/2/17
P226 Disability in Crohn’s Disease Patients at diagnosis: Findings from the CROCO (Crohn´ s Disease Cohort) study
Journal of Crohn's and Colitis
2024/1/1
P683 Economic impact of achieving mucosal healing on UC-related hospitalisations and work productivity in patients with moderately to severely active UC: A post-hoc analysis of …
Journal of Crohn's and Colitis
2024/1/1
Humoral immune response and safety of SARS‐CoV‐2 vaccination in very early onset inflammatory bowel disease
Journal of Pediatric Gastroenterology and Nutrition
2024/2/14
Early Use of Biologics Reduces Healthcare Costs in Crohn’s Disease: Results from a United States Population-Based Cohort
Digestive Diseases and Sciences
2024/1
Methods of monitoring inflammatory bowel diseases
2024/2/8
DEVELOPMENT OF CROHN'S DISEASE IN PATIENT PRESENTING WITH COMPLEX PERIANAL FISTULA TO A TERTIARY MEDICAL CARE CENTER
2024/2/1
Ryan Ungaro
H-Index: 23
INCREASING ACCESS TO INTERDISCIPLINARY IBD CARE FOR NEWLY DIAGNOSED IBD PATIENTS USING TELEMEDICINE: AN EXTENSION OF THE COMPASS-IBD PROGRAM
Gastroenterology
2024/2/1
Perceptions of patients with Inflammatory Bowel Disease and first degree relatives on prediction and prevention of disease
Inflammatory bowel diseases
2015/1/1